![Ruggero Fariello](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ruggero Fariello
Corporate Officer/Principal bij SeneXta Therapeutics SA
Profiel
Ruggero Fariello is the founder of Newron Pharmaceuticals SpA, which was founded in 1999.
He held the title of Non-Executive Director from 1999 to 2007.
Dr. Fariello is currently a Member-Executive Board at SeneXta Therapeutics SA, starting in 2008.
Dr. Fariello has held former positions as Chairman & Professor at Rush University, Director-Research & Development at CNS, Inc. (Delaware), Director-Research & Development at Thomas Jefferson University, Senior Consultant at Pharmacia & Upjohn, Inc., and Chief Medical Officer at Neurotune AG.
Dr. Fariello obtained a doctorate degree from the University of Turin in 1965.
Actieve functies van Ruggero Fariello
Bedrijven | Functie | Begin |
---|---|---|
SeneXta Therapeutics SA
![]() SeneXta Therapeutics SA Medical SpecialtiesHealth Technology SeneXta Therapeutics SA engages in the research and development of therapies for neurodegenerative disorders. The firm provides medicines that maintain healthy brain ageing and rehabilitation after ischemic brain injury. The company was founded by Enrico Braglia and Federica Pericle in 2008 and is headquartered in Lugano, Switzerland. | Corporate Officer/Principal | 18-09-2009 |
Eerdere bekende functies van Ruggero Fariello
Bedrijven | Functie | Einde |
---|---|---|
NEWRON PHARMACEUTICALS S.P.A. | Oprichter | 21-05-2007 |
Neurotune AG
![]() Neurotune AG Pharmaceuticals: MajorHealth Technology Neurotune AG develops medications for neuropathic pain and sarcopenia. The firm is developing treatments which modulate the connections between nerve cells and its target cells. The company was founded by Bruno Oesch in January 2005 and is headquartered in Schlieren-Zurich, Switzerland. | Hoofd Techniek/Wetenschap/O&O | 20-02-2013 |
Thomas Jefferson University | Hoofd Techniek/Wetenschap/O&O | - |
Pharmacia & Upjohn, Inc. | Corporate Officer/Principal | - |
CNS, Inc. (Delaware)
![]() CNS, Inc. (Delaware) Food RetailRetail Trade CNS, Inc. manufactures pharmaceutical products and health supplements. It markets the products as a treatment for allergies, snoring, and general nasal congestion. The company also sells FiberChoice, a chewable fiber supplement and a Breathe Right-branded throat rinse for snorers. It was founded in 1982 and is headquartered in Minneapolis, MN. | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Ruggero Fariello
University of Turin | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
NEWRON PHARMACEUTICALS S.P.A. | Health Technology |
Bedrijven in privébezit | 4 |
---|---|
SeneXta Therapeutics SA
![]() SeneXta Therapeutics SA Medical SpecialtiesHealth Technology SeneXta Therapeutics SA engages in the research and development of therapies for neurodegenerative disorders. The firm provides medicines that maintain healthy brain ageing and rehabilitation after ischemic brain injury. The company was founded by Enrico Braglia and Federica Pericle in 2008 and is headquartered in Lugano, Switzerland. | Health Technology |
CNS, Inc. (Delaware)
![]() CNS, Inc. (Delaware) Food RetailRetail Trade CNS, Inc. manufactures pharmaceutical products and health supplements. It markets the products as a treatment for allergies, snoring, and general nasal congestion. The company also sells FiberChoice, a chewable fiber supplement and a Breathe Right-branded throat rinse for snorers. It was founded in 1982 and is headquartered in Minneapolis, MN. | Retail Trade |
Pharmacia & Upjohn, Inc. | Health Technology |
Neurotune AG
![]() Neurotune AG Pharmaceuticals: MajorHealth Technology Neurotune AG develops medications for neuropathic pain and sarcopenia. The firm is developing treatments which modulate the connections between nerve cells and its target cells. The company was founded by Bruno Oesch in January 2005 and is headquartered in Schlieren-Zurich, Switzerland. | Health Technology |